KOSELUGO 7.5 mg/1 (Selumetinib GRANULE) 7.5 mg/1

Koselugo 7.5 mg/1 granules are an oral medication used to manage specific conditions. This prescription drug is designed for targeted therapeutic use, offering a convenient granule form for administration.

Strength

7.5 mg/1

Pack Size

60 GRANULE in 1 BOTTLE (0310-0640-60)

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Koselugo 7.5 mg/1 granules are primarily used for the treatment of certain medical conditions. The drug is formulated to provide relief and management for specific health issues. What is Koselugo used for? It is often prescribed to address particular symptoms and conditions as determined by a healthcare provider.

Side Effects

Common effects of Koselugo 7.5 mg/1 granules may include gastrointestinal discomfort and changes in appetite. Some users might experience fatigue or mild skin irritation. These effects can vary depending on individual health factors and the specific condition being treated.

Precautions & Warnings

Koselugo 7.5 mg/1 granules should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Store the medication in a cool, dry place away from direct sunlight and out of reach of children.

Avoid Interactions

Koselugo 7.5 mg/1 granules may interact with certain medications, including those that affect liver enzymes. It is advisable to consult a healthcare provider before combining Koselugo with other drugs, especially those known to interact with CYP inhibitors. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Koselugo is used to manage specific medical conditions as prescribed by a healthcare provider.

Koselugo granules should be taken orally, following the instructions provided by your healthcare provider.

Common side effects may include gastrointestinal discomfort, changes in appetite, fatigue, and mild skin irritation.

Koselugo may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

Koselugo should be stored in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.